Skip to main content
NewslettersWatchlist

Biomerica Inc(BMRA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low0.6100
Day High0.6590
Open:0.6161
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Globe Newswire
Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam
Globe Newswire
Biomerica to Participate at BTIG Biotech Conference
AccessWire
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
Globe Newswire
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
Globe Newswire
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population
Globe Newswire
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
Globe Newswire
Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome
Globe Newswire
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
Globe Newswire
Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
Globe Newswire
Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening
Globe Newswire
Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment
Globe Newswire
Biomerica Launches New Website for Its Aware® Breast Exam Device
Globe NewsWire
Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week
Globe NewsWire
Biomerica Reports Fiscal 2021 Year End Results
Globe NewsWire
Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression
Globe NewsWire
Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test
AccessWire
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
Globe NewsWire
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
Globe NewsWire
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
Globe NewsWire
Biomerica to Participate in Upcoming Investor Conferences
AccessWire
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
Globe NewsWire
Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab
Globe NewsWire
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
Globe NewsWire
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
Globe NewsWire
Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark
Globe NewsWire
Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment
Globe NewsWire
Biomerica Reports Fiscal 2021 1st Quarter Financial Results
Globe NewsWire
Biomerica Reports Fiscal Year End May 31, 2020 Financial Results
Globe NewsWire
Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors
Globe NewsWire
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests
Globe NewsWire
Biomerica Announces Filing of New Three Year Shelf Registration Statement
Globe NewsWire
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial

Profile

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.